Pharsight Monthly Summary
JANUARY, 2023
Recent happenings in patent protected drugs.
spacer_11
At a Glance
104
drug patents lapsed
Photos
47
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ABBVIE
 
ACER
 
ACROTECH BIOPHARMA
 
ASTRAZENECA
 
AXSOME
 
BAUSCH AND LOMB INC
 
BIOFRONTERA
 
CEPHALON
 
CHIESI
 
DECIPHERA PHARMS
 
GALDERMA LABS LP
 
GILEAD SCIENCES INC
 
HELSINN HLTHCARE
 
INCYTE CORP
 
JANSSEN BIOTECH
 
JAZZ
 
LA JOLLA PHARMA
 
LUNDBECK PHARMS LLC
 
NOVARTIS
 
PHARMACOSMOS
 
POLAREAN
 
SALIX PHARMS
 
SCYNEXIS
 
SEAGEN
 
SHANDONG LUYE
 
VERO BIOTECH INC
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
AFREZZA 7305986 Jan, 2023
AFREZZA 8156936 Jan, 2023
AFREZZA 7305986 Jan, 2023
AFREZZA 8156936 Jan, 2023
AFREZZA 7305986 Jan, 2023
AFREZZA 8156936 Jan, 2023
APIDRA 6960561 Jan, 2023
APIDRA 6960561 Jan, 2023
APIDRA SOLOSTAR 6960561 Jan, 2023
COMBIGAN 7323463 Jan, 2023
DEXILANT SOLUTAB 6664276 Jan, 2023
DOPTELET 8765764 Jan, 2023
EFFIENT 8569325 Jan, 2023
EFFIENT 8569325 Jan, 2023
ENTRESTO 8404744 Jan, 2023
ENTRESTO 8796331 Jan, 2023
ENTRESTO 8404744 Jan, 2023
ENTRESTO 8796331 Jan, 2023
ENTRESTO 8404744 Jan, 2023
ENTRESTO 8796331 Jan, 2023
IBRANCE 6936612 Jan, 2023
IBRANCE 7208489 Jan, 2023
IBRANCE 7456168 Jan, 2023
IBRANCE 6936612 Jan, 2023
IBRANCE 7208489 Jan, 2023
IBRANCE 7456168 Jan, 2023
IBRANCE 6936612 Jan, 2023
IBRANCE 7208489 Jan, 2023
IBRANCE 7456168 Jan, 2023
IBRANCE 6936612 Jan, 2023
IBRANCE 7456168 Jan, 2023
IBRANCE 6936612 Jan, 2023
IBRANCE 7456168 Jan, 2023
IBRANCE 6936612 Jan, 2023
IBRANCE 7456168 Jan, 2023
INTUNIV 6811794*PED Jan, 2023
INTUNIV 6811794*PED Jan, 2023
INTUNIV 6811794*PED Jan, 2023
INTUNIV 6811794*PED Jan, 2023
JANUMET 6699871*PED Jan, 2023
JANUMET 7125873*PED Jan, 2023
JANUMET 6699871*PED Jan, 2023
JANUMET 7125873*PED Jan, 2023
JANUMET XR 6699871*PED Jan, 2023
JANUMET XR 7125873*PED Jan, 2023
JANUMET XR 6699871*PED Jan, 2023
JANUMET XR 7125873*PED Jan, 2023
JANUMET XR 6699871*PED Jan, 2023
JANUMET XR 7125873*PED Jan, 2023
JANUVIA 6699871*PED Jan, 2023
JANUVIA 7125873*PED Jan, 2023
JANUVIA 6699871*PED Jan, 2023
JANUVIA 7125873*PED Jan, 2023
JANUVIA 6699871*PED Jan, 2023
JANUVIA 7125873*PED Jan, 2023
JUVISYNC 6699871*PED Jan, 2023
JUVISYNC 7125873*PED Jan, 2023
JUVISYNC 6699871*PED Jan, 2023
JUVISYNC 7125873*PED Jan, 2023
JUVISYNC 6699871*PED Jan, 2023
JUVISYNC 7125873*PED Jan, 2023
JUVISYNC 6699871*PED Jan, 2023
JUVISYNC 7125873*PED Jan, 2023
JUVISYNC 6699871*PED Jan, 2023
JUVISYNC 7125873*PED Jan, 2023
JUVISYNC 6699871*PED Jan, 2023
JUVISYNC 7125873*PED Jan, 2023
LATISSE 8632760 Jan, 2023
LATISSE 8758733 Jan, 2023
LATISSE 8926953 Jan, 2023
LATISSE 8986715 Jan, 2023
LATISSE 9216183 Jan, 2023
LATISSE 9226931 Jan, 2023
NOURIANZ 7727994 Jan, 2023
NOURIANZ 7727994 Jan, 2023
OZURDEX 10076526 Jan, 2023
OZURDEX 10702539 Jan, 2023
OZURDEX 8034366 Jan, 2023
OZURDEX 8034370 Jan, 2023
OZURDEX 8506987 Jan, 2023
OZURDEX 9192511 Jan, 2023
SAVELLA 6602911 Jan, 2023
SAVELLA 6602911 Jan, 2023
SAVELLA 6602911 Jan, 2023
SAVELLA 6602911 Jan, 2023
STEGLUJAN 6699871*PED Jan, 2023
STEGLUJAN 6699871*PED Jan, 2023
SYMBICORT 10166247 Jan, 2023
SYMBICORT 11311558 Jan, 2023
SYMBICORT 7759328 Jan, 2023
SYMBICORT 8143239 Jan, 2023
SYMBICORT 8575137 Jan, 2023
SYMBICORT 10166247 Jan, 2023
SYMBICORT 11311558 Jan, 2023
SYMBICORT 7759328 Jan, 2023
SYMBICORT 8143239 Jan, 2023
SYMBICORT 8575137 Jan, 2023
TOVIAZ 6858650*PED Jan, 2023
TOVIAZ 6858650*PED Jan, 2023
VANOS 7220424 Jan, 2023
VIZAMYL 7351401 Jan, 2023
VIZAMYL 8691185 Jan, 2023
VIZAMYL 7351401 Jan, 2023
VIZAMYL 8691185 Jan, 2023
Newly introduced Drug Patents
Drug Patent Patent expiry
AIRSUPRA 9415009 May, 2030
AKYNZEO 11529362 Jun, 2037
AMELUZ 11540981 Feb, 2028
AUVELITY 11534414 Nov, 2034
AUVELITY 11541021 Nov, 2034
AUVELITY 11541048 Nov, 2034
BREXAFEMME 11534433 Jun, 2039
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER 11547758 Apr, 2027
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER 11547758 Apr, 2027
CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER 11547758 Apr, 2027
CARNEXIV 11529357 Jan, 2040
COSELA 11529352 Jul, 2039
EPSOLAY 11541026 Feb, 2040
ERLEADA RE49353 Sep, 2033
GENOSYL 11511252 Sep, 2029
GIAPREZA 11559559 Dec, 2034
KHAPZORY 11541012 Mar, 2039
LEQVIO 11530408 May, 2024
LOTEMAX SM 11534395 Jan, 2036
OLPRUVA 11154521 Oct, 2036
OLPRUVA 11202767 Oct, 2036
OLPRUVA 11433041 Oct, 2036
OPZELURA 11510923 Sep, 2040
ORIAHNN (COPACKAGED) 11542239 Jul, 2039
ORILISSA 11542239 Jul, 2039
QINLOCK 11529336 Aug, 2040
QINLOCK 11534432 Aug, 2040
RINVOQ 11524964 Oct, 2036
RINVOQ 11535624 Oct, 2036
RINVOQ 11535625 Oct, 2036
RINVOQ 11535626 Oct, 2036
RYKINDO 10098882 Apr, 2032
RYKINDO 10406161 Apr, 2032
RYKINDO 11110094 Apr, 2032
RYKINDO 9446135 Apr, 2032
RYKINDO 9532991 Apr, 2032
SUNLENCA 10071985 Aug, 2037
SUNLENCA 10654827 Aug, 2037
SUNLENCA 11267799 Aug, 2038
SUNLENCA 9951043 Feb, 2034
TREANDA 9533955*PED Sep, 2029
TUKYSA 11207324 Apr, 2038
VRAYLAR RE49302 Jul, 2029
XENOVIEW 10583205 Feb, 2035
XENOVIEW 11052161 Dec, 2035
XIFAXAN 11564912 Feb, 2029
XYWAV 11554102 Jan, 2033
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2023 GreyB Research